Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

SAMS™, the next-generation integrated screening solution, is designed to meet all your Sanctions, PEP and Adverse Media Screening requirements. Our proprietary database contains 600+ global/regional sanctions and watchlists, 5,000,000+ PEP entries and Adverse Media, from more than 55,000 sources in 50+ different languages. It is updated in real-time. It is also flexible enough to add 3rd party databases or internal databases. SAMS™, powered by intuitive workflows created by leading industry experts, automates the initial customer screening process and ongoing monitoring processes. It is designed with robust controls, a complete audit track for regulatory reporting and powerful visualization tools to aid in decision-making.

Description

adWATCH - AE is a solution designed to aid pharmaceutical companies in handling and documenting adverse events that arise during clinical trials. It provides a quick and efficient way for reporters at clinics, hospitals, or investigative sites to create and oversee Adverse Event Reports (AERs), ensuring proper reporting to regulatory bodies and government organizations. An adverse effect refers to a harmful or undesirable reaction experienced by a patient due to medications or medical devices. The process of documenting adverse events necessitates thorough tracking of all medical complaint case details, which culminates in the creation of MedWatch reports, CIOMS reports, and other management documentation. With adWATCH - AE, researchers, physician investigators, Contract Research Organizations (CROs), clinical trial experts, and various health professionals can easily generate and submit AERs in compliance with FDA requirements, adhering to both MedWatch and CIOMS formats. This streamlined process not only enhances regulatory compliance but also improves patient safety oversight during clinical trials.

API Access

Has API Yes 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

Amazon Yes 
Amazon API Gateway Yes 

Integrations

Amazon No 
Amazon API Gateway No 

Pricing Details

$500/month/user
Customized pricing based on volumes, deployment model, and other customizations.
Free Trial Yes 
Free Version No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises Yes 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person No 

Vendor Details

Company Name

Solytics Partners

Founded

2019

Country

United States

Website

www.solytics-partners.com

Vendor Details

Company Name

Atlant Systems

Website

atlantsystems.com/atlant/solutions/atwatch-ae/

Product Features

AML

Behavioral Analytics No 
Case Management Yes 
Compliance Reporting Yes 
Identity Verification No 
Investigation Management Yes 
PEP Screening Yes 
Risk Assessment Yes 
SARs No 
Transaction Monitoring No 
Watch List Yes 

Product Features

CAPA

Audit Management No 
CAPA Planning No 
Change Management No 
Complaint Management No 
Incident Management No 
Nonconformance Tracking No 
Quality Control No 
Risk Management No 
Root Cause Analysis No 
Training Management No 

Alternatives

NameScan Reviews

NameScan

MemberCheck

Alternatives

Compliance Catalyst Reviews

Compliance Catalyst

Moody's Corporation
cubeSAFETY Reviews

cubeSAFETY

CRScube
GRID Reviews

GRID

Moody's Corporation
Evidex Reviews

Evidex

Advera Health Analytics